Lupin profit and loss

Latest FY26
Revenue
₹27,958cr+23.1% on FY25
EBITDA
₹8,816cr+66.9% on FY25
Net profit
₹5,355cr+62.0% on FY25
EPS
₹116.75+62.3% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
29,96727,95822,70820,01116,642
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
47642419612073.4
30,44228,38222,90420,13116,715
Expenses
4,8074,6224,4574,1423,688
2,9952,8672,6432,9592,938
−158−162−258−457154
4,8754,5753,9643,4953,087
452434295312274
1,5291,3761,1691,197881
7,9107,2416,6186,0624,977
22,41020,95218,88917,70915,999
9,5388,8165,2833,8111,798
8,0097,4414,1142,614917
Profit
8,0327,4304,0152,422716
−558−5580.00.00.0
7,4746,8734,0152,422716
2,0211,527991634246
−97.5−10.3−282−14722.4
1,9231,517709487269
−0.00.00.00.00.0
5,5515,3553,3061,936448
5,5515,3553,3061,936448
316440−91.537.624.2
5,8675,7963,2151,973472
5,5295,3333,2821,914430
22.222.624.621.117.6
Per share
₹121.01₹116.75₹71.95₹42.05₹9.46
₹120.73₹116.44₹71.69₹41.87₹9.41
Other comprehensive income — detail
316440−91.5——
3.9−6.4−23.4−13.7−1.6
3.4−0.1−8.0——
———−4.7−0.9
302420−76.150.611.7
−13.0−27.10.0——
———3.9−13.2
5,8425,7683,1901,955450
24.427.424.618.021.7
Per share — as-filed variants
₹121.01₹116.75₹71.95₹42.05₹9.46
₹120.73₹116.44₹71.69₹41.87₹9.41
Derived — gross profit (revenue − materials − purchases − Δ inventories)
22,32320,63215,86613,3679,862
74.5%73.8%69.9%66.8%59.3%
Adjusted (ex-exceptional items) — derived
8,0327,4304,0152,422716
−558−5580.00.00.0
5,9655,7903,3061,936448
₹130.04₹126.23₹71.95₹42.05₹9.46
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

LUPIN₹1,972.70

Lupin Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersSUNPHARMACIPLADRREDDYALKEMFORTISAUROPHARMALAURUSLABSMANKINDMcap ₹90,192 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations16,641.720,010.822,707.927,958.029,966.6
Other Income73.4120.2195.8424.5475.7
Total Income16,715.020,131.022,903.728,382.530,442.3
Expenses
+ Cost of Materials Consumed3,687.84,142.24,457.44,621.94,806.9
+ Purchases of Stock-in-Trade2,938.22,958.72,642.62,867.02,995.3
+ Changes in Inventories153.7-457.4-257.8-162.5-158.5
+ Employee Benefit Expense3,087.23,494.63,964.24,574.54,874.5
+ Finance Costs274.3311.6294.9434.5452.4
+ Depreciation & Amortisation880.71,196.81,169.31,375.51,529.4
+ Other Expenses4,976.66,062.36,618.17,241.07,910.0
Total Expenses15,998.517,708.718,888.720,952.022,410.0
EBITDA1,798.13,810.55,283.38,816.09,538.3
EBIT917.42,613.74,114.17,440.58,008.9
Profit
PBT before Exceptional Items716.52,422.34,015.07,430.58,032.3
+ Exceptional Items0.00.00.0-557.9-557.9
Pretax Income716.52,422.34,015.06,872.67,474.4
+ Current Tax246.4633.9990.71,527.42,020.9
+ Deferred Tax22.4-147.2-282.0-10.3-97.5
Tax Expense268.8486.7708.71,517.11,923.4
+ Share of Associates & JVs0.00.00.00.0-0.0
Net Income447.71,935.63,306.35,355.55,551.0
+ Net Income — Continuing Ops447.71,935.63,306.35,355.55,551.0
+ Other Comprehensive Income24.237.6-91.5440.4315.7
Total Comprehensive Income471.91,973.23,214.85,795.95,866.7
Net Income to Common430.11,914.53,281.65,332.85,528.8
Minority Interest17.621.124.622.622.2
Per Share
Basic EPS9.4642.0571.95116.75121.01
Diluted EPS9.4141.8771.69116.44120.73
Other Comprehensive Income — detail
+ Other Comprehensive Income——-91.5440.4315.7
+ Items NOT to be Reclassified to P&L-1.6-13.7-23.4-6.43.9
+ Tax on Items NOT to be Reclassified——-8.0-0.13.4
+ Tax on Items NOT to be Reclassified — alt tag-0.9-4.7———
+ Items to be Reclassified to P&L11.750.6-76.1419.6302.2
+ Tax on Items to be Reclassified——0.0-27.1-13.0
+ Tax on Items to be Reclassified — alt tag-13.23.9———
Comprehensive Income — Owners of Parent450.31,955.23,190.25,768.55,842.3
Comprehensive Income — Non-controlling Interests21.718.024.627.424.4
Per Share — as-filed variants
Basic EPS — Continuing Operations9.4642.0571.95116.75121.01
Diluted EPS — Continuing Operations9.4141.8771.69116.44120.73
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit9,861.913,367.415,865.720,631.622,322.8
Gross Margin %59.2666.8069.8773.7974.49
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)716.52,422.34,015.07,430.58,032.3
− Exceptional Items (reconciliation)0.00.00.0-557.9-557.9
Net Income Adj (tax-effected)447.71,935.63,306.35,790.25,965.3
EPS Adj9.4642.0571.95126.23130.04
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.00
Paid Up Equity Capital91.091.191.391.491.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.